(TLX) Talanx - Overview
Sector: Financial ServicesIndustry: Insurance - Diversified | Exchange XETRA (Germany) | Currency EUR | Market Cap: 31.110m | Total Return 7.1% in 12m
Stock: Insurance, Reinsurance, Life, Property, Casualty
Total Rating 34
Risk 34
Buy Signal -0.95
| Risk 5d forecast | |
|---|---|
| Volatility | 24.0% |
| Relative Tail Risk | -5.92% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.31 |
| Alpha | 1.19 |
| Character TTM | |
|---|---|
| Beta | 0.381 |
| Beta Downside | 0.371 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.11% |
| CAGR/Max DD | 2.07 |
EPS (Earnings per Share)
Revenue
Description: TLX Talanx March 05, 2026
Talanx AG is a German insurance company. It offers a wide range of insurance and reinsurance products globally.
The companys offerings span various insurance types, including life, casualty, property, and specialized coverage like aviation and cyber risks. Reinsurance, a core component of the insurance industry, involves insurers transferring portions of their risk portfolios to other insurers.
Talanx also provides bancassurance products, which are insurance products distributed through banks, and engages in asset management. The companys diverse portfolio reflects the multi-line insurance business model, which aims to diversify risk and revenue streams across different insurance segments. For further detailed analysis, explore ValueRay.
Headlines to watch out for
- Premium growth in property/casualty insurance boosts revenue
- Reinsurance segment performance impacts profitability
- Investment income fluctuations affect overall earnings
- Natural catastrophe events increase claims payouts
- Regulatory changes in insurance sector pose compliance risks
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 2.48b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.59 > 1.0 |
| NWC/Revenue: 26.42% < 20% (prev -1.20%; Δ 27.62% < -1%) |
| CFO/TA 0.06 > 3% & CFO 12.01b > Net Income 2.48b |
| Net Debt (3.22b) to EBITDA (5.30b): 0.61 < 3 |
| Current Ratio: error (cannot be calculated; needs correct Total Current Assets and Liabilities) |
| Outstanding Shares: last quarter (258.2m) vs 12m ago 0.24% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 27.97% > 50% (prev 13.78%; Δ 14.19% > 0%) |
| Interest Coverage Ratio: 22.17 > 6 (EBITDA TTM 5.30b / Interest Expense TTM 229.0m) |
Altman Z'' 0.93
| A: 0.07 (Total Current Assets 13.82b - Total Current Liabilities 0.0) / Total Assets 193.71b |
| B: 0.06 (Retained Earnings 12.35b / Total Assets 193.71b) |
| C: 0.03 (EBIT TTM 5.08b / Avg Total Assets 187.07b) |
| D: 0.07 (Book Value of Equity 11.78b / Total Liabilities 172.82b) |
| Altman-Z'' Score: 0.93 = BB |
Beneish M -0.49
| DSRI: 3.33 (Receivables 8.56b/1.22b, Revenue 52.33b/24.87b) |
| GMI: 0.90 (GM 100.0% / 90.32%) |
| AQI: 0.94 (AQ_t 0.92 / AQ_t-1 0.99) |
| SGI: 2.10 (Revenue 52.33b / 24.87b) |
| TATA: -0.05 (NI 2.48b - CFO 12.01b) / TA 193.71b) |
| Beneish M-Score: -0.49 (Cap -4..+1) = D |
What is the price of TLX shares?
As of March 28, 2026, the stock is trading at EUR 103.00 with a total of 117,910 shares traded.
Over the past week, the price has changed by -1.15%, over one month by -3.74%, over three months by -8.93% and over the past year by +7.05%.
Over the past week, the price has changed by -1.15%, over one month by -3.74%, over three months by -8.93% and over the past year by +7.05%.
Is TLX a buy, sell or hold?
Talanx has no consensus analysts rating.
What are the forecasts/targets for the TLX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 118 | 14.6% |
| Analysts Target Price | - | - |
TLX Fundamental Data Overview March 24, 2026
Market Cap USD = 31.11b (26.91b EUR * 1.1562 EUR.USD)
P/E Trailing = 11.4631
P/E Forward = 10.4712
P/S = 0.5872
P/B = 2.1187
P/EG = 0.8584
Revenue TTM = 52.33b EUR
EBIT TTM = 5.08b EUR
EBITDA TTM = 5.30b EUR
Long Term Debt = 6.74b EUR (estimated: total debt 8.48b - short term 1.73b)
Short Term Debt = 1.73b EUR (from shortTermDebt, last quarter)
Debt = 8.48b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.22b EUR (from netDebt column, last quarter)
Enterprise Value = 30.12b EUR (26.91b + Debt 8.48b - CCE 5.26b)
Interest Coverage Ratio = 22.17 (Ebit TTM 5.08b / Interest Expense TTM 229.0m)
EV/FCF = 3.80x (Enterprise Value 30.12b / FCF TTM 7.92b)
FCF Yield = 26.29% (FCF TTM 7.92b / Enterprise Value 30.12b)
FCF Margin = 15.13% (FCF TTM 7.92b / Revenue TTM 52.33b)
Net Margin = 4.74% (Net Income TTM 2.48b / Revenue TTM 52.33b)
Gross Margin = unknown ((Revenue TTM 52.33b - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = 0.16 (Enterprise Value 30.12b / Total Assets 193.71b)
Interest Expense / Debt = 0.66% (Interest Expense 56.0m / Debt 8.48b)
Taxrate = 23.02% (265.0m / 1.15b)
NOPAT = 3.91b (EBIT 5.08b * (1 - 23.02%))
Current Ratio = unknown (Total Current Assets 13.82b / Total Current Liabilities 0.0)
Debt / Equity = 0.63 (Debt 8.48b / totalStockholderEquity, last quarter 13.47b)
Debt / EBITDA = 0.61 (Net Debt 3.22b / EBITDA 5.30b)
Debt / FCF = 0.41 (Net Debt 3.22b / FCF TTM 7.92b)
Total Stockholder Equity = 12.58b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.33% (Net Income 2.48b / Total Assets 193.71b)
RoE = 19.71% (Net Income TTM 2.48b / Total Stockholder Equity 12.58b)
RoCE = 26.27% (EBIT 5.08b / Capital Employed (Equity 12.58b + L.T.Debt 6.74b))
RoIC = 26.23% (NOPAT 3.91b / Invested Capital 14.90b)
WACC = 5.69% (E(26.91b)/V(35.38b) * Re(7.32%) + D(8.48b)/V(35.38b) * Rd(0.66%) * (1-Tc(0.23)))
Discount Rate = 7.32% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF] Terminal Value 86.07% ; FCFF base≈8.12b ; Y1≈7.91b ; Y5≈7.96b
[DCF] Fair Price = 906.0 (EV 237.17b - Net Debt 3.22b = Equity 233.95b / Shares 258.2m; r=6.0% [WACC]; 5y FCF grow -3.72% → 3.0% )
EPS Correlation: 82.57 | EPS CAGR: 20.42% | SUE: -1.10 | # QB: 0
Revenue Correlation: -14.19 | Revenue CAGR: 10.86% | SUE: 0.48 | # QB: 0
EPS current Year (2026-12-31): EPS=10.62 | Chg7d=+0.152 | Chg30d=+0.152 | Revisions Net=-1 | Growth EPS=+10.7% | Growth Revenue=+3.8%
EPS next Year (2027-12-31): EPS=10.94 | Chg7d=-0.054 | Chg30d=-0.054 | Revisions Net=-1 | Growth EPS=+3.0% | Growth Revenue=+6.4%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -0.8% (Discount Rate 7.9% - Earnings Yield 8.7%)
[Growth] Growth Spread = +7.2% (Analyst 6.4% - Implied -0.8%)
P/E Trailing = 11.4631
P/E Forward = 10.4712
P/S = 0.5872
P/B = 2.1187
P/EG = 0.8584
Revenue TTM = 52.33b EUR
EBIT TTM = 5.08b EUR
EBITDA TTM = 5.30b EUR
Long Term Debt = 6.74b EUR (estimated: total debt 8.48b - short term 1.73b)
Short Term Debt = 1.73b EUR (from shortTermDebt, last quarter)
Debt = 8.48b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.22b EUR (from netDebt column, last quarter)
Enterprise Value = 30.12b EUR (26.91b + Debt 8.48b - CCE 5.26b)
Interest Coverage Ratio = 22.17 (Ebit TTM 5.08b / Interest Expense TTM 229.0m)
EV/FCF = 3.80x (Enterprise Value 30.12b / FCF TTM 7.92b)
FCF Yield = 26.29% (FCF TTM 7.92b / Enterprise Value 30.12b)
FCF Margin = 15.13% (FCF TTM 7.92b / Revenue TTM 52.33b)
Net Margin = 4.74% (Net Income TTM 2.48b / Revenue TTM 52.33b)
Gross Margin = unknown ((Revenue TTM 52.33b - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = 0.16 (Enterprise Value 30.12b / Total Assets 193.71b)
Interest Expense / Debt = 0.66% (Interest Expense 56.0m / Debt 8.48b)
Taxrate = 23.02% (265.0m / 1.15b)
NOPAT = 3.91b (EBIT 5.08b * (1 - 23.02%))
Current Ratio = unknown (Total Current Assets 13.82b / Total Current Liabilities 0.0)
Debt / Equity = 0.63 (Debt 8.48b / totalStockholderEquity, last quarter 13.47b)
Debt / EBITDA = 0.61 (Net Debt 3.22b / EBITDA 5.30b)
Debt / FCF = 0.41 (Net Debt 3.22b / FCF TTM 7.92b)
Total Stockholder Equity = 12.58b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.33% (Net Income 2.48b / Total Assets 193.71b)
RoE = 19.71% (Net Income TTM 2.48b / Total Stockholder Equity 12.58b)
RoCE = 26.27% (EBIT 5.08b / Capital Employed (Equity 12.58b + L.T.Debt 6.74b))
RoIC = 26.23% (NOPAT 3.91b / Invested Capital 14.90b)
WACC = 5.69% (E(26.91b)/V(35.38b) * Re(7.32%) + D(8.48b)/V(35.38b) * Rd(0.66%) * (1-Tc(0.23)))
Discount Rate = 7.32% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF] Terminal Value 86.07% ; FCFF base≈8.12b ; Y1≈7.91b ; Y5≈7.96b
[DCF] Fair Price = 906.0 (EV 237.17b - Net Debt 3.22b = Equity 233.95b / Shares 258.2m; r=6.0% [WACC]; 5y FCF grow -3.72% → 3.0% )
EPS Correlation: 82.57 | EPS CAGR: 20.42% | SUE: -1.10 | # QB: 0
Revenue Correlation: -14.19 | Revenue CAGR: 10.86% | SUE: 0.48 | # QB: 0
EPS current Year (2026-12-31): EPS=10.62 | Chg7d=+0.152 | Chg30d=+0.152 | Revisions Net=-1 | Growth EPS=+10.7% | Growth Revenue=+3.8%
EPS next Year (2027-12-31): EPS=10.94 | Chg7d=-0.054 | Chg30d=-0.054 | Revisions Net=-1 | Growth EPS=+3.0% | Growth Revenue=+6.4%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -0.8% (Discount Rate 7.9% - Earnings Yield 8.7%)
[Growth] Growth Spread = +7.2% (Analyst 6.4% - Implied -0.8%)